Vitamin E supplementation: What's the harm in that?

Clinical Trials

Volumn 6, Issue 1, 2009, Pages 47-49

  Miller III, Edgar R ^a,b,c,d   Guallar, Eliseo ^a,b,c,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PLACEBO;

ANTIOXIDANT ACTIVITY; CAUSAL ATTRIBUTION; CLINICAL STUDY; CLINICAL TRIAL; DOSE RESPONSE; DRUG MEGADOSE; DRUG SAFETY; HUMAN; MORTALITY; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; BAYES THEOREM; DATA INTERPRETATION, STATISTICAL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; META-ANALYSIS AS TOPIC; MORTALITY; VITAMIN E;

EID: 62149149143     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774509103248     Document Type: Note

References (11)

1. Miller ER 3rd, Pastor-Barriuso R., Dalal D. et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142 (1): 37-46.
2. Bjelakovic G., Nikolova D., Gluud LL et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297 (8): 842-857.
3. Bairati I., Meyer F., Jobin E. et al. Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients. Int J Cancer 2006; 119 (9): 2221-2224.
4. Lee IM, Cook NR, Gaziano JM et al. Vitamin E in the primary prevention of cardiovascular diAease and cancer: The Women's Health Study: a randomized controlled trial. JAMA 2005; 294 (1): 56-65.
5. Cook NR, Albert CM, Gaziano JM et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007; 167 (15): 1610-1618.
6. Lonn E., Bosch J., Yusuf S. et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial. JAMA 2005; 293 (11): 1338-1347.
7. Belch J., MacCuish A., Campbell I. et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008; 337: a1840.
8. Ford ES, Ajani UA, Mokdad AH Brief communication: The prevalence of high intake of vitamin E from the use of supplements among U.S. adults. Ann Intern Med 2005; 143 (2): 116-120.
9. Tilburt JC, Emanuel EJ, Miller FG Does the evidence make a difference in consumer behavior? Sales of supplements before and after publication of negative research results. J Gen Intern Med 2008; 23 (9): 1495-1498.
10. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994; 330 (15): 1029-1035.
11. Brigelius-Flohe R. Adverse effects of vitamin E by induction of drug metabolism. Genes Nutr 2007; 2 (3): 249-256.